These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Surgeon General's advisory on alcohol/drug use. N Y State Dent J; 1979 Oct; 45(8):424. PubMed ID: 291832 [No Abstract] [Full Text] [Related]
4. Minimizing the menace of OTC drugs. Tabor M Occup Health Saf; 1982 May; 51(5):14-9. PubMed ID: 7078915 [No Abstract] [Full Text] [Related]
5. "Deadly duo' still number one killer. Am Pharm; 1980 Dec; NS20(12):15. PubMed ID: 7457354 [No Abstract] [Full Text] [Related]
6. How pharmacists serve the special needs of visually-impaired patrons. Pharm Times; 1978 Jun; 44(6):60-6. PubMed ID: 10307777 [No Abstract] [Full Text] [Related]
7. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643 [TBL] [Abstract][Full Text] [Related]
9. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach. Kuhlik BN Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984 [No Abstract] [Full Text] [Related]
10. America's top problem drug. Small WE Am Pharm; 1979 Dec; 19(13):5. PubMed ID: 517425 [No Abstract] [Full Text] [Related]
11. Pharmacist-managed patient-care services and prescriptive authority in the U.S. Public Health Service. Herrier RN; Boyce RW; Apgar DA Hosp Formul; 1990 Jan; 25(1):67-8, 76-8, 80. PubMed ID: 10103538 [TBL] [Abstract][Full Text] [Related]
12. Drugs and alcohol: patient information. Blackburn JL; Hawes EM Can J Hosp Pharm; 1977; 30(3):73-5, 87. PubMed ID: 10304735 [No Abstract] [Full Text] [Related]
13. The expanded role of pharmacists in the Public Health Service: an overview of a pharmacy practice model. Church RM Hosp Formul; 1989 Sep; 24(9):526-7, 530, 532. PubMed ID: 10294667 [TBL] [Abstract][Full Text] [Related]
14. Stoning a dead bird: advertising limits on approved new drugs. Strobos J Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018 [No Abstract] [Full Text] [Related]
15. The prescribing continuum: between prescription and over-the-counter drugs. Lyles A Clin Ther; 2007 Oct; 29(10):2244-5. PubMed ID: 18042481 [No Abstract] [Full Text] [Related]
16. The pharmacist in home health care: Part III--Safety, optimum use, and accountability of drugs. Abrams M; Fedder DO; Lamy PR Caring; 1984 Aug; 3(8):13-6. PubMed ID: 10267204 [No Abstract] [Full Text] [Related]
17. Using electronic health information for pharmacovigilance: the promise and the pitfalls. Rosati K J Health Life Sci Law; 2009 Jul; 2(4):171, 173-239. PubMed ID: 19673181 [TBL] [Abstract][Full Text] [Related]
18. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium. Garbutt BJ; Hofmann ME Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558 [No Abstract] [Full Text] [Related]
19. Canadian drugs: panacea or problem? State Legis; 2004 Jun; 30(6):9. PubMed ID: 15179953 [No Abstract] [Full Text] [Related]
20. Black box warnings in prescription drug labeling: results of a survey of 206 drugs. Beach JE; Faich GA; Bormel FG; Sasinowski FJ Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718 [No Abstract] [Full Text] [Related] [Next] [New Search]